124 results on '"Jürgenliemk-Schulz, Ina"'
Search Results
2. Individualized 3D-printed applicators for magnetic resonance imaging-guided brachytherapy in nasal vestibule cancer
3. EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer
4. Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer
5. Multi-center dosimetric predictions to improve plan quality for brachytherapy for cervical cancer treatment
6. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
7. Online adaptive MR-guided radiotherapy: Conformity of contour adaptation for prostate cancer, rectal cancer and lymph node oligometastases among radiation therapists and radiation oncologists
8. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases
9. The impact of para-aortic lymph node irradiation on disease-free survival in patients with cervical cancer: A systematic review and meta-analysis
10. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study
11. Comparison of Library of Plans with two daily adaptive strategies for whole bladder radiotherapy
12. 596: The utilisation of brachytherapy in Europe – A BrachyHERO survey.
13. Adaptive radiotherapy: The Elekta Unity MR-linac concept
14. Individual lymph nodes: “See it and Zap it”
15. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort
16. Importance of training in external beam treatment planning for locally advanced cervix cancer: Report from the EMBRACE II dummy run
17. Implementation of state-of-the-art (chemo)radiation for advanced cervix cancer in the Netherlands: A quality improvement program
18. Evaluation of plan adaptation strategies for stereotactic radiotherapy of lymph node oligometastases using online magnetic resonance image guidance
19. Cervical cancer apparent diffusion coefficient values during external beam radiotherapy
20. 3408: Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer
21. 1446: MARGARITA: MRLinac Boost for Gynecological Cancers if brachytherapy is not feasible. Initial results
22. 919: Randomised trial of nurse-led sexual rehabilitation after radiotherapy for gynaecological cancers
23. 890: Impact of cumulative cisplatin-dose on distant metastasis after chemoradiation of cervical cancer
24. Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study
25. Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer
26. Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study
27. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
28. Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer
29. The feasibility of semi-automatically generated red bone marrow segmentations based on MR-only for patients with gynecologic cancer
30. First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac
31. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases
32. Comparison of Library of Plans with two daily adaptive strategies for whole bladder radiotherapy
33. Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases
34. Evaluation of plan adaptation strategies for stereotactic radiotherapy of lymph node oligometastases using online magnetic resonance image guidance
35. Cervical cancer apparent diffusion coefficient values during external beam radiotherapy
36. Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study.
37. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
38. Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases.
39. Evidence-Based Dose Planning Aims and Dose Prescription in Image-Guided Brachytherapy Combined With Radiochemotherapy in Locally Advanced Cervical Cancer.
40. Management of Nodal Disease in Advanced Cervical Cancer.
41. SP-0003 EMBR ACE experience.
42. Internal motion of the vagina after hysterectomy for gynaecological cancer
43. Variation of treatment planning parameters (D90 HR-CTV, D2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: Comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose–volume constraints
44. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer
45. Motion and deformation of the target volumes during IMRT for cervical cancer: What margins do we need?
46. Prevention of pterygium recurrence by postoperative single-dose β-irradiation: a prospective randomized clinical double-blind trial
47. Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study.
48. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
49. Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.
50. In response to Dr. Leung et al.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.